Kate Dilligan: The Close of Our Oversubscribed $11M Series A led by Mutual Capital Partners
Kate Dilligan, Founder and CEO of Cooler Heads Care, shared a post on LinkedIn:
“I am thrilled to announce the close of our oversubscribed $11M series A led by Mutual Capital Partners with participation by Scientific Health Development, Crescent Ridge VC, NuFund Venture Group, California Innovation Fund, Robin Hood Ventures, Golden Seeds and HIP. In addition, Jason Pesterfield has joined our board as an outside director joining Liz Todia, R. Michael Schotzinger, PhD, Maria Gonzalez-Blanch, and me.
Cooler Heads Care is making hair loss from chemotherapy a thing of the past by helping infusion centers integrate scalp cooling into their standard of care. I am so grateful for our fantastic investors and outstanding team.
Read more posts on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023